PROTAGENIC THERAPEUTICS INC (PTIX:NASDAQ)
$0.585 -0.1048 (-15.1928%)
Analysed PROTAGENIC THERAPEUTICS INC (PTIX:NASDAQ) News Sources
Protagenic Therapeutics Completes Phytanix Separation, Strengthens Balance Sheet and Repositions the Company Around PT00114
17-03-2026
yahoo.com
Protagenic Therapeutics Upgrades from OTC Pink to OTCQB Venture Market
10-03-2026
yahoo.com
Results from Phase 1 Multiple-Dose Study of PT00114
09-12-2025
yahoo.com
Protagenic Therapeutics Announces Receipt of Nasdaq Non-Compliance Notice
27-11-2025
yahoo.com
Protagenic Therapeutics Announces Completion of Enrollment and Dosing in Phase 1 MAD Study
13-11-2025
yahoo.com
Protagenic Therapeutics Provides Update on Form 10-Q Filing Timeline and Nasdaq Compliance
22-08-2025
yahoo.com
Sector Update: Health Care Stocks Mixed Late Afternoon
21-08-2025
yahoo.com
Top Midday Gainers
21-08-2025
yahoo.com
Sector Update: Health Care Stocks Advance in Afternoon Trading
21-08-2025
yahoo.com
BC-Most Active Stocks
21-08-2025
yahoo.com
What is the current price of PROTAGENIC THERAPEUTICS INC (PTIX:NASDAQ)?
The current price of PROTAGENIC THERAPEUTICS INC (PTIX:NASDAQ) is $0.585.
PROTAGENIC THERAPEUTICS INC (PTIX:NASDAQ) absolute price change since previous trading day?
The absolute price change of PROTAGENIC THERAPEUTICS INC (PTIX:NASDAQ) since the previous trading day is $-0.1048.
PROTAGENIC THERAPEUTICS INC (PTIX:NASDAQ) percentage price change since previous trading day?
The percentage price change of PROTAGENIC THERAPEUTICS INC (PTIX:NASDAQ) since the previous trading day is -15.1928%.
What is the most recent average sentiment score for PROTAGENIC THERAPEUTICS INC (PTIX:NASDAQ)?
The most recent average sentiment score for PROTAGENIC THERAPEUTICS INC (PTIX:NASDAQ) is 80 out of 100.
What is the most recent average sentiment for PROTAGENIC THERAPEUTICS INC (PTIX:NASDAQ)?
The most recent sentiment for PROTAGENIC THERAPEUTICS INC (PTIX:NASDAQ) is .
SEC-8K** Filing Available For PROTAGENIC THERAPEUTICS INC (PTIX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.